HOME Research Insight The demand for contract research services for cell based assay development is expected to increase in the coming years, as these services help to make the drug discovery process more cost efficient and less time consuming



The demand for contract research services for cell based assay development is expected to increase in the coming years, as these services help to make the drug discovery process more cost efficient and less time consuming


Services segment will be the fastest growing segment from 2013 to 2018. The declining R&D budgets, the need for cost-effective and time-saving drug discovery services and leveraging upon newer technologies are influencing the companies and academia to follow risk-sharing outsourcing strategies. With the rising trend of outsourcing, CROs are gaining popularity as pharmaceutical companies can cut down on their operational costs and R&D budgets. A number of outsourcing partnerships with CROs has led to an increased consumption of cell-based assay products by this segment. With respect to cell-based assay applications, predictive toxicology will be the fastest growing market in the forecast period from 2013 to 2018. Switch from biochemical assays to cell-based assays for use in toxicology studies is a significant factor that is propelling the market of cell-based assay in predictive toxicology.

Several drug discovery and toxicity screening procedures are now adopting cell-based assay screening owing to the technological and cost benefits that these solutions offer over as compared to conventional methods such as animal testing and biochemical assays. The technology is aimed at high throughput and cost and time effective solutions, which is attracting new end users.

The emerging segment in cell-based assay consumables market is stem cell lines which is expected to grow at a brisk pace in the coming years. Induced pluripotent stem cell lines are expected to be the major contributor in stem cell lines market due to range of benefits over other cell lines. Due to rising need of technological advancements for detection of cell-based assays, label-free detection and high content screening are expected to reach the highest growth in coming years. The market for label-free detection is expected to gain popularity among suppliers in the coming five years and is also poised to grow at a high CAGR from 2013 to 2018.

Geographic analysis has revealed that the Asian market including China and India are the most promising destinations for the cell-based assay outsourcing due to the mushrooming CROs market. Since, these countries have seen expanding cell-based research activities and offer low labour and material costs, good technical expertise, the adoption of cell-based assay products has increased in this region

Related Reports:

Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports